Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Susana Torres‐Martínez"'
Autor:
Susana Torres‐Martínez, Silvia Calabuig‐Fariñas, Andrea Moreno‐Manuel, Giulia Bertolini, Alejandro Herreros‐Pomares, Eva Escorihuela, Elena Duréndez‐Saéz, Ricardo Guijarro, Ana Blasco, Luca Roz, Carlos Camps, Eloisa Jantus‐Lewintre
Publikováno v:
Molecular Oncology, Vol 18, Iss 1, Pp 190-215 (2024)
Despite the success of therapies in lung cancer, more studies of new biomarkers for patient selection are urgently needed. The present study aims to analyze the role of galectin‐3 (GAL‐3) in the lung tumor microenvironment (TME) using tumorsphere
Externí odkaz:
https://doaj.org/article/e94f49441c4e4aeda21fd85df71bca0e
Autor:
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloisa Jantus-Lewintre
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17587 (2023)
Immunotherapy has been proven a viable treatment option for non-small cell lung cancer (NSCLC) treatment in patients. However, some patients still do not benefit. Finding new predictive biomarkers for immunocheckpoint inhibitor (ICI) response will im
Externí odkaz:
https://doaj.org/article/4dff53ea28344440a8c674c8c3cb60c4
Autor:
Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres Martínez, José Ángel García-García, Vega Iranzo González-Cruz, Carlos Camps Herrero
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therap
Externí odkaz:
https://doaj.org/article/ed8878228d67443994a91fff5ce314e6
Autor:
Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz, Carlos Camps Herrero
Publikováno v:
Cancers
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
Cancers, Vol 14, Iss 307, p 307 (2022)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
Cancers, Vol 14, Iss 307, p 307 (2022)
Simple Summary Breast cancer (BC) is the most common malignant neoplasm in women and one of the leading causes of cancer death in women worldwide. Programmed death-ligand 1 (PD-L1) is becoming an emerging biomarker in BC in recent years. It has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c427a13568d5089cfe9090bc94ab6567
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3925
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3925
